Cancer Genetics and Epigenetics 2024, Vol.12, No.6, 317-328 http://medscipublisher.com/index.php/cge 327 Montagut C., Argilés G., Ciardiello F., Poulsen T., Dienstmann R., Kragh M., Kopetz S., Lindsted T., Ding C., Vidal J., Clausell-Tormos J., Siravegna G., Sánchez-Martín F.J., Koefoed K., Pedersen M.W., Grandal M.M., Dvorkin M., Wyrwicz L., Rovira A., Cubillo A., Salazar R., Desseigne F., Nadal C., Albanell J., Zagonel V., Siena S., Fumi G., Rospo G., Nadler P., Horak I., Bardelli A., and Tabernero J., 2018, Efficacy of Sym004 in patients with metastatic colorectal cancer with acquired resistance to Anti-EGFR therapy and molecularly selected by circulating tumor DNA analyses: A Phase 2 Randomized Clinical Trial, JAMA Oncology, 4(4): e175245. https://doi.org/10.1001/jamaoncol.2017.5245 PMID: 29423521 PMCID: PMC5885274 Nakayama M., and Oshima M., 2018, Mutant p53 in colon cancer, Journal of Molecular Cell Biology, 11(4): 267-276. https://doi.org/10.1093/jmcb/mjy075 Ogunwobi O.O., Mahmood F., and Akingboye A., 2020, Biomarkers in colorectal cancer: current research and future prospects, International Journal of Molecular Sciences, 21(15): 5311. https://doi.org/10.3390/ijms21155311 PMID: 32726923 PMCID: PMC7432436 Osumi H., Shinozaki E., Takeda Y., Wakatsuki T., Ichimura T., Saiura A., Yamaguchi K., Takahashi S., Noda T., and Zembutsu H., 2018, Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer, Cancer Medicine, 8(1): 408-417. https://doi.org/10.1002/cam4.1913 PMID: 30575318 PMCID: PMC6346227 Raskov H., Søby J.H., Troelsen J., Bojesen R.D., and Gögenur I., 2019, Driver gene mutations and epigenetics in colorectal cancer, Annals of Surgery, 271(1): 75-85. https://doi.org/10.1097/SLA.0000000000003393 Rebuzzi F., Ulivi P., and Tedaldi G., 2023, Genetic predisposition to colorectal cancer: how many and which genes to test? International Journal of Molecular Sciences, 24(3): 2137. https://doi.org/10.3390/ijms24032137 PMID: 36768460 PMCID: PMC9916931 Reece M., Saluja H., Hollington P., Karapetis C., Vatandoust S., Young G., and Symonds E., 2019, The use of circulating tumor DNA to monitor and predict response to treatment in colorectal cancer, Frontiers in Genetics, 10: 1118. https://doi.org/10.3389/fgene.2019.01118 PMID: 31824558 PMCID: PMC6881479 Rhead B., Hein D., Pouliot Y., Guinney J., Francisco M., Vega D., and Sanford N., 2023, Association of genetic ancestry with molecular tumor profiles in colorectal cancer, Genome Med., 16(1): 99. https://doi.org/10.1101/2023.07.12.23292571 PMID: 39138508 PMCID: PMC11321170 Santos W.D., Reis M.B.D., Porto J., de Carvalho A.C., Matsushita M., Oliveira G., Syrjänen K., Reis R.M., and Guimarães D.P., 2021, Somatic targeted mutation profiling of colorectal cancer precursor lesions, BMC Medical Genomics, 15(1): 143. https://doi.org/10.1186/s12920-022-01294-w PMID: 35761395 PMCID: PMC9238170 Santos W.D., Sobanski T., de Carvalho A.C., Evangelista A.F., Matsushita M., Berardinelli G.N., de Oliveira M.A., Reis R.M., and Guimarães D.P., 2019, Mutation profiling of cancer drivers in Brazilian colorectal cancer, Scientific Reports, 9(1): 13687. https://doi.org/10.1038/s41598-019-49611-1 PMID: 31548566 PMCID: PMC6757044 Shida D., Kuchiba A., Shibata T., Hamaguchi T., Yamasaki S., Ito M., Kobatake T., Tonooka T., Masaki T., Shiozawa M., Takii Y., Uetake H., Okamura S., Ojima H., Kazama S., Takeyama H., Kanato K., Shimada Y., Murakami Y., and Kanemitsu Y., 2023, Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910, Cancer Science, 114(8): 3352-3363. https://doi.org/10.1111/cas.15834 PMID: 37189003 PMCID: PMC10394152 Singh M.P., Rai S., Pandey A., Singh N.K., and Srivastava S., 2019, Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine, Genes and Diseases, 8(2): 133-145. https://doi.org/10.1016/j.gendis.2019.10.013 PMID: 33997160 PMCID: PMC8099693 Suzuki T., Suzuki T., Yoshimura Y., Yahata M., Yew P.Y., Nakamura T., Nakamura Y., Park J.H., and Matsuo R., 2020, Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers, Oncotarget, 11(34): 3198-3207. https://doi.org/10.18632/oncotarget.27682 Telysheva E.N., Shaikhaev E.G., and Snigireva G., 2022, Mutational profile of KRAS-positive colorectal cancer, Siberian Journal of Oncology, 21(1): 47-56 https://doi.org/10.21294/1814-4861-2022-21-1-47-56 Tsilimigras D.I., Ntanasis-Stathopoulos I., Bagante F., Moris D., Cloyd J., Spartalis E., and Pawlik T.M., 2018, Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: a systematic review of the current evidence, Surgical Oncology, 27(2): 280-288. https://doi.org/10.1016/j.suronc.2018.05.012
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==